Public Sector Pension Investment Board Increases Stock Position in Embecta Corp. $EMBC

Public Sector Pension Investment Board raised its position in Embecta Corp. (NASDAQ:EMBC) by 57.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 314,129 shares of the company’s stock after acquiring an additional 114,902 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.54% of Embecta worth $4,432,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of EMBC. Exchange Traded Concepts LLC lifted its stake in Embecta by 519.2% in the third quarter. Exchange Traded Concepts LLC now owns 124,429 shares of the company’s stock worth $1,756,000 after acquiring an additional 104,334 shares during the period. Teacher Retirement System of Texas lifted its position in shares of Embecta by 365.7% in the 3rd quarter. Teacher Retirement System of Texas now owns 372,451 shares of the company’s stock worth $5,255,000 after purchasing an additional 292,477 shares during the period. Squarepoint Ops LLC lifted its position in shares of Embecta by 103.6% in the 2nd quarter. Squarepoint Ops LLC now owns 403,412 shares of the company’s stock worth $3,909,000 after purchasing an additional 205,311 shares during the period. American Century Companies Inc. boosted its stake in shares of Embecta by 36.3% during the 2nd quarter. American Century Companies Inc. now owns 5,195,948 shares of the company’s stock valued at $50,349,000 after purchasing an additional 1,382,537 shares in the last quarter. Finally, Allianz Asset Management GmbH raised its stake in Embecta by 68.4% in the second quarter. Allianz Asset Management GmbH now owns 52,044 shares of the company’s stock worth $504,000 after buying an additional 21,144 shares in the last quarter. 93.83% of the stock is owned by institutional investors.

Embecta Stock Up 0.5%

Shares of EMBC opened at $10.53 on Friday. The stock has a market cap of $623.59 million, a P/E ratio of 4.44 and a beta of 1.11. The business’s 50 day moving average price is $11.50 and its 200-day moving average price is $12.92. Embecta Corp. has a 52 week low of $9.20 and a 52 week high of $15.72.

Embecta (NASDAQ:EMBC) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.04. Embecta had a negative return on equity of 26.66% and a net margin of 12.92%.The business had revenue of $261.20 million during the quarter, compared to analysts’ expectations of $258.07 million. During the same quarter in the previous year, the business earned $0.65 earnings per share. The firm’s quarterly revenue was down .3% compared to the same quarter last year. Embecta has set its FY 2026 guidance at 2.800-3.00 EPS. On average, equities analysts anticipate that Embecta Corp. will post 2.85 EPS for the current year.

Embecta Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Friday, February 27th will be paid a $0.15 dividend. The ex-dividend date is Friday, February 27th. This represents a $0.60 dividend on an annualized basis and a yield of 5.7%. Embecta’s payout ratio is presently 25.32%.

Analyst Ratings Changes

Several analysts have weighed in on EMBC shares. BTIG Research reaffirmed a “buy” rating and set a $25.00 price objective on shares of Embecta in a research report on Friday, February 6th. Weiss Ratings restated a “hold (c-)” rating on shares of Embecta in a research note on Wednesday, January 21st. Finally, Wall Street Zen lowered Embecta from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 7th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $18.50.

About Embecta

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.